Publications by authors named "Svenja Pichlmeier"
Background Contrast-unenhanced abdominal CT is the imaging standard for urinary calculi detection; however, studies comparing photon-counting detector (PCD) CT and energy-integrating detector (EID) CT dose-reduction potentials are lacking. Purpose To compare the radiation dose and image quality of optimized EID CT with those of an experimental PCD CT scan protocol including tin prefiltration in patients suspected of having urinary calculi. Materials and Methods This retrospective single-center study included patients who underwent unenhanced abdominal PCD CT or EID CT for suspected urinary caliculi between February 2022 and March 2023.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates ways to reduce radiation doses in abdominal CT scans for diagnosing kidney stones, using spectral shaping and tube voltage modulation.
- Eight cadaveric specimens were scanned at different tube voltages and doses, and the image quality was evaluated both quantitatively and subjectively by radiologists.
- Results showed that using a tin filter at 100 kVp provided better image quality at lower doses compared to higher voltages and conventional imaging methods, indicating effective radiation dose reduction without compromising diagnostic quality.
Pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at advanced tumor stages with chemotherapy as the only treatment option. Transcriptomic analysis has defined a classical and basal‑like PDAC subtype, which are regulated by epigenetic modification. The present study aimed to determine if drug‑induced epigenetic reprogramming of pancreatic cancer cells affects PDAC subtype identity and chemosensitivity.
View Article and Find Full Text PDFBackground & Aims: Changes to the microenvironment of pancreatic ductal adenocarcinomas (PDACs) have been associated with poor outcomes of patients. We studied the associations between composition of the pancreatic stroma (fibrogenic, inert, dormant, or fibrolytic stroma) and infiltration by inflammatory cells and times of progression-free survival (PFS) of patients with PDACs after resection.
Methods: We obtained 1824 tissue microarray specimens from 385 patients included in the European Study Group for Pancreatic Cancer trial 1 and 3 and performed immunohistochemistry to detect alpha smooth muscle actin, type 1 collagen, CD3, CD4, CD8, CD68, CD206, and neutrophils.